Evidence map›Paper›PMID 35447934›Full record

Trial reportMarine drugs2022

The Effects of Freshwater Clam (

Tse-Hung Huang, Chiao-Hsu Ke, Chin-Chang Chen, Cheng-Hsun Chuang, Kuang-Wen Liao, Yi-Hsien Shiao, Chen-Si Lin

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Synergistic Effects ofAntioxidants (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Tse-Hung HuangDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung City 20401, Taiwan.ORCID 0000-0002-5231-9932
Chiao-Hsu KeDepartment of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No. 1 Sec. 4 Roosevelt Rd., Taipei City 10617, Taiwan.ORCID 0000-0001-9602-9630
Chin-Chang ChenDepartment of Anatomy, School of Medicine, China Medical University, Taichung City 40402, Taiwan.
Cheng-Hsun ChuangInstitute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu City 30068, Taiwan.ORCID 0000-0002-4571-3608
Kuang-Wen LiaoInstitute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu City 30068, Taiwan.
Yi-Hsien ShiaoDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung City 20401, Taiwan.
Chen-Si LinDepartment of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No. 1 Sec. 4 Roosevelt Rd., Taipei City 10617, Taiwan.ORCID 0000-0003-2254-8344
National Taiwan University · TWNational Yang Ming Chiao Tung University · TWChang Gung Memorial Hospital · TWChina Medical University · TWMing Chi University of Technology · TW

Funding

Council of Agriculture, Taiwan, 110AS-10.1.7-AD-U1Ministry of Science and Technology in Taiwan MOST 109-2320-B-182A013-MY2VGHUST Joint Research Program 111-G6-2-2
6 · The paper itself

Abstract

Freshwater clam extract (FCE) is a functional food that regulates the immune system and has been demonstrated in numerous studies to display desirable anti-tumor necrosis factor-alpha (TNF-α) responses. In addition, excess TNF-α production is positively associated with type 2 diabetes. However, few longitudinal clinical studies evaluating the efficiency and toxicity of FCE are available. This article reports that patients with prediabetes who received FCE had a desirable outcome of a reduction in serum TNF-α for a long period. This was a double-blind, randomized, parallel clinical trial conducted using FCE intervention and placebo groups, and 36 patients with prediabetes were enrolled. Two grams of FCE or placebo was consumed daily for 180 consecutive days. The serum of the participants was collected at four time points (0M: before the intervention; 3M: after 3 months of intervention; 6M: after 6 months of intervention; 12M: 6 months after cessation of intervention at 6M). A serum TNF-α concentration higher than 4.05 pg/mL was defined as a cut-off value. FCE reduced serum TNF-α in all participants at 6M and 12M. Moreover, FCE significantly suppressed serum TNF-α concentrations at 6M and 12M and inhibited TNF-α release with time series in subjects with elevated TNF-α values. FCE intervention effectively reduced serum TNF-α and persistently sustained the effects for half a year in patients with prediabetes. Gas chromatography-mass spectrometry (GS-MS) analysis revealed that the major components of FCE were phytosterols and fatty acids, which exerted anti-inflammatory and anti-TNF-α abilities. Hence, FCE has the potential to be developed as a natural treatment for prediabetic patients in Taiwan.

Indexed as

CorbiculaDiabetes Mellitus, Type 2Prediabetic StateAnimalsFresh WaterHumansPlant ExtractsTaiwanTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsPlant ExtractsTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsCorbicula flumineafreshwater clam extractprediabetestumor necrosis factor-alpha

Identifiers

PMID35447934
PMCPMC9027770
OpenAlexW4223412049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.